Establishment Labs Holdings Inc. (ESTA) is a Healthcare stock trading at $84.76 (as of 2026-06-18), with a market capitalization of $2.08B and a trailing P/E of -48.1. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Establishment Labs Holdings Inc. manufactures and markets medical devices used in aesthetic and reconstructive plastic surgery, including silicone gel-filled breast implants and related Motiva products such as gravity-sensitive implants and a tissue expander. The company also distributes Puregraft products for autologous adipose tissue harvesting and redistribution, selling through distributors and direct sales in Europe, Latin America, Asia-Pacific, and other international markets.